Efficacy of Contractility Modulation Therapy in Patients with Transthyretin Amyloid Cardiomyopathy, Mildly Reduced to Reduced EF and NYHA III and IV: A Multicentric, Prospective Pilot Study for AMY-CCM Registry

Background: Transthyretin cardiac amyloidosis (ATTR-CM) is an infiltrative cardiomyopathy that frequently progresses to symptomatic heart failure (HF), often with mildly reduced or reduced ejection fraction (EF). Standard therapies are limited in NYHA III–IV, and Tafamidis is approved only for the e...

Descripció completa

Dades bibliogràfiques

Autors principals:	Procolo Marchese, Francesca Gennaro, Giovanni Mazzotta, Pierfrancesco Grossi, Luigi Cocchiara, Stefano Guarracini, Lorenzo Mazzocchetti, Matteo Ziacchi, Mauro Biffi, Roberta Magnano, Massimo Di Marco, Matteo Ruzzolini, Antonio Bisignani, Matteo Bianco, Paolo Garrone, Walter Grosso Marra, Margherita Cannillo, Carlo Lavalle, Daniele Masarone, Cristina Chimenti
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2025-09-01
Col·lecció:	Journal of Cardiovascular Development and Disease
Matèries:	amyloidosis cardiac contractility modulation heart failure
Accés en línia:	https://www.mdpi.com/2308-3425/12/10/380
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!